Originally established in 2015, the Texas Compassionate Use Program (T.CUP) allows limited access to low-THC (.5%) cannabis for certain patients. In spite of being expanded in 2019, T.CUP remains one of the most restrictive medical cannabis programs in the nation. In addition to limited patient access, the program lacks accountability because independent, third-party labs are barred from testing the medicine. Our panelist will discuss the program from their perspectives as caregivers of patients, physicians, and licensed providers in Texas.